Literature DB >> 1317464

The Chemical Use, Abuse, and Dependence Scale (CUAD). Rationale, reliability, and validity.

M P McGovern1, D H Morrison.   

Abstract

This article describes the rationale for the development of the Chemical Use, Abuse, and Dependence Scale (CUAD). The instrument is in a semistructured interview format; it derives both substance use severity scores and DSM-III-R substance use disorder diagnoses and can be administered in a short period with minimal training. The reliability and validity of the CUAD are reported and appear satisfactory. The CUAD is recommended for use as a detection, diagnostic, and treatment selection index in clinical, research, and program evaluation contexts.

Mesh:

Substances:

Year:  1992        PMID: 1317464     DOI: 10.1016/0740-5472(92)90007-b

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  6 in total

1.  Issues and outcomes in integrated treatment programs for dual disorders.

Authors:  J M Jerrell; J L Wilson; D C Hiller
Journal:  J Behav Health Serv Res       Date:  2000-08       Impact factor: 1.505

Review 2.  Measuring addiction propensity and severity: the need for a new instrument.

Authors:  Kevin P Conway; Janet Levy; Michael Vanyukov; Redonna Chandler; Joni Rutter; Gary E Swan; Michael Neale
Journal:  Drug Alcohol Depend       Date:  2010-05-11       Impact factor: 4.492

3.  Do Unremitted Psychotic Symptoms Have an Effect on the Brain? A 2-Year Follow-up Imaging Study in First-Episode Psychosis.

Authors:  Martin Lepage; Carolina Makowski; Michael Bodnar; M Mallar Chakravarty; Ridha Joober; Ashok K Malla
Journal:  Schizophr Bull Open       Date:  2020-08-24

4.  Drug use disorder (DUD) questionnaire: scale development and validation.

Authors:  Michael Scherer; C Debra Furr-Holden; Robert B Voas
Journal:  Eval Rev       Date:  2013-05-27

5.  A five-year randomized parallel and blinded clinical trial of an extended specialized early intervention vs. regular care in the early phase of psychotic disorders: study protocol.

Authors:  Danyael Lutgens; Srividya Iyer; Ridha Joober; Thomas G Brown; Ross Norman; Eric Latimer; Norbert Schmitz; Amal Abdel Baki; Sherezad Abadi; Ashok Malla
Journal:  BMC Psychiatry       Date:  2015-02-14       Impact factor: 3.630

6.  Validation of a three-item Fatigue Severity Scale for patients with substance use disorder: a cohort study from Norway for the period 2016-2020.

Authors:  Jørn Henrik Vold; Rolf Gjestad; Christer F Aas; Eivind Meland; Kjell Arne Johansson; Lars Thore Fadnes
Journal:  Health Qual Life Outcomes       Date:  2021-03-02       Impact factor: 3.186

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.